CLOSED STUDIES / Ovarian Cancer


GEICO 0702-T/TOPO IIA


Title

Determination of the TOPO IIA expression in ovarian carcinoma samples from patients treated with pegylated liposomal doxorubicin.


GEICO Coordinator

Dr. Antonio González


Patients Recruited

45


Inclusion Closing Date

December of 2008


Publication

ECCO – ESMO 2009. Póster 8025. Comunicación Oral SEOM 2009. Correlation of Topo II alpha expression and amplification with efficacy of pegylated liposomal doxorubicin in a GEICO phase II trial for platinum-resistant (PR) recurrent ovarian carcinoma (ROC). Dr. Antonio Gonzalez-Martin, Antonio Casado, Isabel Bover , Ana Herrero , Ana Santaballa , Cristina Caballero , Cristina Churruca , Elisa Calvo , Rosa Nadal , Belén Ojeda. – Manuscrito en fase de elaboración.